PAAS National https://validator.w3.org/feed/docs/rss2.html New COVID-19 Booster Dose & The Final Frontier of the PREP Act 2023 Health and Human Services Language Access Plan Released: New Plan, Same Goal Caremark Notice of Breach – Aberrant Practices and Trends Announcing the PAAS Rx Days’ Supply Calculator App 2024 DMEPOS Series #2: Nebulizer Solutions Documentation is Essential for Prescription Quantity Changes Why Do You Need a HIPAA Risk Analysis? Ask Change Healthcare… High AWP Omeprazole leads to $2.3M Medicaid Fraud Case 2024 Self-Audit Series #2: DAW Codes Walgreens Reaches $360 Million Settlement with Humana Regarding Inflated Prescription Drug Prices Numerous Sumatriptan Formulations Cause Headaches for Pharmacies, & Potential Recoupments Caremark Invoice Audits – Purchases from Other Pharmacies Qualified Medicare Beneficiary (QMB) Program Bowel Prep Products – What Quantity and Days’ Supply to Bill? Cybersecurity Incident at Change Healthcare – Documentation is Key to Reducing Audit Risk! Best Practices When Filling & Billing Afrezza® Required: Proof of Patient Copay Collection Early Refills of Titrated Medications Lead to Recoupments Miebo™ Eye Drops – What is the Days’ Supply? 2024 Self-Audit Series #1: Insulin Prescriptions Continuous Glucose Monitor (CGM) Billing and Supply Allowance NDC Numbers: Not a Guarantee of FDA Approval Be on the Lookout for Eye Drops Requiring Extra Billing Consideration Painful Lessons: What You Should Know About Return to Stock Timeframes Dosing Increments for Insulin Pens 2024 DMEPOS Series #1: Diabetic Test Strips A Day in the Life of a PAAS National Analyst – Audits, Billing Questions and FWA/HIPAA support Additional Audit Assistance Member Benefits Addressing “Weird” Days’ Supply 2024 Fraud, Waste & Abuse and HIPAA Compliance Program Updates Days’ Supply Considerations for Eye Medications Tip to Federal Agents Leads to Jail Time for Pharmacy Owner Best Practices for DAW Billing in Pharmacies Insulin Substitution Review: Understanding Purple Book Terminology Adapting to Change: Levemir<sup>®</sup> Phase Out and Its Implications for Pharmacies Caremark Bulk Purchase Notification Inventory Purchase Reminders for Successful Audits Top 10 PAAS National Articles of 2023 DMEPOS Updated Refill Request and Affirmative Response Requirements Law Enforcement Access to Protected Health Information – What’s Your Policy? Be Conscientious When Refusing to Dispense (or Bill Insurance)… Don’t Cut Corners: Notations on Prescriptions Major PBMs Announce “Cost Plus” Pharmacy Networks Prescriber Statements for Successful Appeal 2024 Update: CMS Mandatory E-Prescribing Requirements for Controlled Substances – Final Rule FDA Issues Updates to iPLEDGE<sup>®</sup> REMS Program Employer Pays $4.75 Million after Employee Stole, then Sold, Protected Health Information PBM Prescription Validation Requests Rose 123% in 2023 – What You Need to Know Transfer Tragedy: A Timeworn PBM Target Blog